These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 11866300)

  • 21. [How should hepatitis C be treated? Treatment of hepatitis C with interferon].
    Marcellin P
    Gastroenterol Clin Biol; 1997; 21(1 Pt 2):S81-8. PubMed ID: 9161518
    [No Abstract]   [Full Text] [Related]  

  • 22. Efficacy of low-dose intermittent interferon-alpha monotherapy in patients infected with hepatitis C virus genotype 1b who were predicted or failed to respond to pegylated interferon plus ribavirin combination therapy.
    Akuta N; Suzuki F; Kawamura Y; Yatsuji H; Sezaki H; Suzuki Y; Hosaka T; Kobayashi M; Kobayashi M; Arase Y; Ikeda K; Kumada H
    J Med Virol; 2008 Aug; 80(8):1363-9. PubMed ID: 18551610
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interferon treatment for patients with chronic hepatitis C infected with high viral load of genotype 2 virus.
    Nakamura H; Ogawa H; Kuroda T; Yamamoto M; Enomoto H; Kishima Y; Yoshida K; Ito H; Matsuda M; Noguchi S
    Hepatogastroenterology; 2002; 49(47):1373-6. PubMed ID: 12239945
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Maintenance therapy with ribavirin in patients with chronic hepatitis C who fail to respond to combination therapy with interferon alfa and ribavirin.
    Hoofnagle JH; Ghany MG; Kleiner DE; Doo E; Heller T; Promrat K; Ong J; Khokhar F; Soza A; Herion D; Park Y; Everhart JE; Liang TJ
    Hepatology; 2003 Jul; 38(1):66-74. PubMed ID: 12829988
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of prolonged interferon therapy for patients with chronic hepatitis C with HCV-genotype 1b and high virus load.
    Arase Y; Ikeda K; Tsubota A; Suzuki Y; Saitoh S; Kobayashi M; Kobayashi M; Suzuki F; Akuta N; Someya T; Kumada H
    J Gastroenterol; 2003; 38(2):158-63. PubMed ID: 12640530
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute hepatitis C infection: an indication for alfa interferon therapy?
    van der Vlies CH; Tang TJ; Niesters HG; Zondervan PE; Janssen HL; de Man RA
    Neth J Med; 2000 Jul; 57(1):30-3. PubMed ID: 10863000
    [No Abstract]   [Full Text] [Related]  

  • 27. Hepatitis C infections. From diagnosis to treatment.
    Shobokshi OA
    Saudi Med J; 2003 Jul; 24 Suppl 2():S65-6. PubMed ID: 12897902
    [No Abstract]   [Full Text] [Related]  

  • 28. Principles of interferon induction therapy.
    Layden TJ
    Am J Med; 1999 Dec; 107(6B):71S-73S. PubMed ID: 10653462
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical manifestations and effect of early therapy with interferon-alpha on the course of acute hepatitis C].
    Warunek W; Cieśla A; Zejc-Bajsarowicz M; Janas-Skulina U; Mach T
    Przegl Epidemiol; 2005; 59(2):467-74. PubMed ID: 16190555
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute hepatitis C treatment.
    Lerias de Almeida PR
    Ann Hepatol; 2010; 9 Suppl():107-11. PubMed ID: 20714006
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment of acute hepatitis C].
    Yokosuka O; Mikata R
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):357-60. PubMed ID: 15359821
    [No Abstract]   [Full Text] [Related]  

  • 32. Primary biliary cirrhosis exacerbated by a course of acute hepatitis C and subsequent interferon therapy.
    Yoshikawa M; Mimura M; Shiroi A; Kojima H; Fukui H; Sugimoto Y; Mochi T
    Am J Gastroenterol; 2000 Sep; 95(9):2396-7. PubMed ID: 11007259
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical trial investigates two experimental HCV drugs.
    AIDS Patient Care STDS; 2010 Apr; 24(4):270. PubMed ID: 20402017
    [No Abstract]   [Full Text] [Related]  

  • 34. Acute hepatitis C: dosage and compliance.
    De Rosa F; Cariti G; Di Perri G
    Hepatology; 2006 Aug; 44(2):511; author reply 511-2. PubMed ID: 16871564
    [No Abstract]   [Full Text] [Related]  

  • 35. Maxim and Roche collaborate for development of hepatitis C drug.
    AIDS Read; 2000 Sep; 10(9):545. PubMed ID: 11019452
    [No Abstract]   [Full Text] [Related]  

  • 36. [Successful treatment in a case of type-C fulminant hepatitis with interferon and steroid-pulse therapy, and review of its virological aspects].
    Marusawa H; Yamashita Y; Kajimura K; Kumegawa Y; Takaya H; Katsurada A
    Nihon Shokakibyo Gakkai Zasshi; 1996 Aug; 93(8):583-7. PubMed ID: 8810818
    [No Abstract]   [Full Text] [Related]  

  • 37. Acute hepatitis C in patients undergoing hemodialysis: experience with high-dose interferon therapy.
    Gentile I; Di Flumeri G; Scarica S; Frangiosa A; Foggia M; Reynaud L; Borgia G
    Minerva Urol Nefrol; 2013 Mar; 65(1):83-4. PubMed ID: 23538314
    [No Abstract]   [Full Text] [Related]  

  • 38. [BMS-790 052 - an oral antiviral hepatitis C antiviral in the pipeline].
    Schmitz J
    Pharm Unserer Zeit; 2011 Jan; 40(1):8-9. PubMed ID: 21194074
    [No Abstract]   [Full Text] [Related]  

  • 39. Hepatitis C virus dynamics in vivo and the antiviral efficacy of interferon alfa therapy.
    Thomas HC; Török ME; Foster GR
    Hepatology; 1999 Apr; 29(4):1333-4. PubMed ID: 10094985
    [No Abstract]   [Full Text] [Related]  

  • 40. [HCV core antigen assay and its clinical utility].
    Tanaka E
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):208-13. PubMed ID: 15359794
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.